Lisa Rene is a Cheverly, Maryland based counselor who is specialized as Addiction (Substance Use Disorder) Counselor. Her current practice location is 3003 Hospital Dr, Suite 25, Cheverly. Patients can book an appointment with her at 301-583-7760.
Lisa Rene is a licensed mental health therapist who help individuals struggling with addiction of alcohol, drug, or other substance use disorder. She helps her clients by manage and overcome the psychological, emotional, and behavioral challenges related to substance use. Counselors also work closely with families and support systems to help them better understand their loved one’s illness. SUD counselors help to promote long-term sobriety, emotional stability, and overall mental wellness for both the individual and their family.
Complete Profile:
Lisa Rene speciality, credentials, practice address, contact phone number and fax are as below.
Patients can directly walk in or can call on the below given phone number for appointment.
Name:
Lisa Rene
Specialization:
Addiction (Substance Use Disorder) Counselor
Gender:
Female
Accepts Medicare Assignment:
No
Practice Address:
3003 Hospital Dr, Suite 25, Cheverly, Maryland, 20785-1194
Phone:
301-583-7760
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1477960102
NPI Enumeration Date:
15 Jul, 2014
NPI Last Update On:
15 Jul, 2014
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
3003 Hospital Dr, Suite 25 Cheverly, Maryland
Zip:
20785-1194
Patients can reach Lisa Rene at 3003 Hospital Dr, Suite 25, Cheverly, Maryland or can call to book an appointment on 301-583-7760. *Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 June, 2025.